Lots of steady news here and deals adding to the asset base, and still only 3.48 Mil shares in the float. This could become a classic Biotech blockbuster that rallies to $20/share in the future.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.